h1

h2

h3

h4

h5
h6


001     1007304
005     20250509050352.0
024 7 _ |2 HSB
|a eva571897
024 7 _ |2 ISSN
|a 1522-8517
024 7 _ |2 ISSN
|a 1523-5866
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85208549575
024 7 _ |2 WOS
|a WOS:001263250000001
024 7 _ |2 doi
|a 10.1093/neuonc/noae078
024 7 _ |2 pmid
|a pmid:38970818
037 _ _ |a RWTH-CONV-253658
041 _ _ |a English
100 1 _ |a Galldiks, Norbert
|b 0
|e Corresponding author
245 _ _ |a PET imaging of gliomas: Status quo and quo vadis?
|h online, print
260 _ _ |a Oxford
|b Oxford Univ. Press
|c 2024
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |0 PUB:(DE-HGF)7
|2 PUB:(DE-HGF)
|a Contribution to a book
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
591 _ _ |a Denmark
591 _ _ |a Germany
700 1 _ |0 P:(DE-82)120979
|a Lohmann, Philipp
|b 1
|u rwth
700 1 _ |a Friedrich, Michel
|b 2
700 1 _ |a Werner, Jan-Michael
|b 3
700 1 _ |a Stetter, Isabelle
|b 4
700 1 _ |a Wollring, Michael M.
|b 5
700 1 _ |a Ceccon, Garry
|b 6
700 1 _ |a Stegmayr, Carina
|b 7
700 1 _ |a Krause, Sandra
|b 8
700 1 _ |a Fink, Gereon R.
|b 9
700 1 _ |a Law, Ian
|b 10
700 1 _ |0 P:(DE-82)013919
|a Langen, Karl-Josef
|b 11
|u rwth
700 1 _ |a Tonn, Joerg-Christian
|b 12
770 _ _ |a Theranostics in CNS Tumors
773 _ _ |0 PERI:(DE-600)2094060-9
|a 10.1093/neuonc/noae078
|n 9
|p S185-S198
|t Neuro-Oncology : official journal of the World Federation of Neuro-Oncology
|v 26
|x 1523-5866
909 C O |o oai:publications.rwth-aachen.de:1007304
|p VDB
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)120979
|a RWTH Aachen
|b 1
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)013919
|a RWTH Aachen
|b 11
|k RWTH
914 1 _ |y 2024
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b NEURO-ONCOLOGY : 2022
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
|d 2024-12-11
|w ger
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2024-12-11
915 _ _ |0 StatID:(DE-HGF)9915
|2 StatID
|a IF >= 15
|b NEURO-ONCOLOGY : 2022
|d 2024-12-11
920 1 _ |0 I:(DE-82)532500-2_20140620
|k 532500-2
|l Klinik und Lehrstuhl für Nuklearmedizin
|x 0
920 1 _ |0 I:(DE-82)532500-3_20140620
|k 532500-3
|l Lehr- und Forschungsgebiet Experimentelle und klinische Nuklearmedizin (FZ Jülich)
|x 1
970 _ _ |a eva571897
980 _ _ |a I:(DE-82)532500-2_20140620
980 _ _ |a I:(DE-82)532500-3_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a contb
980 _ _ |a journal


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21